To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Gilead's Hepsera

The FDA granted marketing approval to GILD for its Hepsera adefovir dipivoxil

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE